Home > Insider Trading > Filing (0000899243-20-033832)

Filing Details

Accession Number:: 0000899243-20-033832
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-12-14 21:30:54
Reporting Period:: 2020-12-07

Accepted Time:: 2020-12-14 21:30:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1351288	Gw Pharmaceuticals Plc	GWPH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
941388	Dr W Geoffrey Guy	Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Disposition	2020-12-07	79,596	$10.80	5,421,925	No	4	S	Direct
Ordinary Shares	Disposition	2020-12-07	55,332	$10.87	5,366,593	No	4	S	Direct
Ordinary Shares	Disposition	2020-12-07	136,656	$10.97	5,229,937	No	4	S	Direct
Ordinary Shares	Disposition	2020-12-07	85,980	$11.04	5,143,957	No	4	S	Direct
Ordinary Shares	Disposition	2020-12-07	69,156	$11.13	5,074,801	No	4	S	Direct
Ordinary Shares	Disposition	2020-12-07	14,340	$11.19	5,060,461	No	4	S	Direct
Ordinary Shares	Disposition	2020-12-07	13,260	$11.28	5,047,201	No	4	S	Direct
Ordinary Shares	Disposition	2020-12-07	14,760	$11.40	5,032,441	No	4	S	Direct
Ordinary Shares	Disposition	2020-12-07	10,920	$11.44	5,021,521	No	4	S	Direct
Ordinary Shares	Disposition	2020-12-08	72,936	$10.69	4,948,585	No	4	S	Direct
Ordinary Shares	Disposition	2020-12-08	167,064	$10.76	4,781,521	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Inadvertently late filing.
Represented by American Depository Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($129.58 per ADS). These shares were sold in multiple transactions at prices ranging from $129.02 per ADS (or $10.75 per ordinary share) to $130.00 per ADS (or $10.83 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($130.47 per ADS). These shares were sold in multiple transactions at prices ranging from $130.05 per ADS (or $10.84 per ordinary share) to $131.01 per ADS (or $10.92 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($131.69 per ADS). These shares were sold in multiple transactions at prices ranging from $131.04 per ADS (or $10.92 per ordinary share) to $132.02 per ADS (or $11.00 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($132.43 per ADS). These shares were sold in multiple transactions at prices ranging from $132.02 per ADS (or $11.00 per ordinary share) to $133.01 per ADS (or $11.08 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($133.54 per ADS). These shares were sold in multiple transactions at prices ranging from $133.02 per ADS (or $11.09 per ordinary share) to $134.01 per ADS (or $11.17 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($134.28 per ADS). These shares were sold in multiple transactions at prices ranging from $134.02 per ADS (or $11.17 per ordinary share) to $135.00 per ADS (or $11.25 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($135.41 per ADS). These shares were sold in multiple transactions at prices ranging from $135.10 per ADS (or $11.26 per ordinary share) to $135.80 per ADS (or $11.32 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($136.77 per ADS). These shares were sold in multiple transactions at prices ranging from $136.06 per ADS (or $11.34 per ordinary share) to $137.00 per ADS (or $11.42 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($137.30 per ADS). These shares were sold in multiple transactions at prices ranging from $137.07 per ADS (or $11.42 per ordinary share) to $137.49 per ADS (or $11.46 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($128.24 per ADS). These shares were sold in multiple transactions at prices ranging from $127.69 per ADS (or $10.64 per ordinary share) to $128.68 per ADS (or $10.72 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($129.06 per ADS). These shares were sold in multiple transactions at prices ranging from $128.70 per ADS (or $10.73 per ordinary share) to $129.63 per ADS (or $10.80 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.